Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1927-1935
Published online before print March 31, 2008, doi: 10.1161/CIRCULATIONAHA.107.757955
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/15/1927    most recent
CIRCULATIONAHA.107.757955v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Darbar, D.
Right arrow Articles by Roden, D. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darbar, D.
Right arrow Articles by Roden, D. M.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

(Circulation. 2008;117:1927-1935.)
© 2008 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation

Dawood Darbar, MD; Prince J. Kannankeril, MD; Brian S. Donahue, MD, PhD; Gayle Kucera, RN; Tanya Stubblefield, RN; Jonathan L. Haines, PhD; Alfred L. George, Jr, MD; Dan M. Roden, MD

From the Departments of Medicine (D.D., G.K., T.S., A.L.G., D.M.R.), Pediatrics (P.J.K.), Anesthesiology (B.S.D.), and Pharmacology (A.L.G., D.M.R.) and the Center for Human Genetics Research (J.L.H.), Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Dawood Darbar, MD, Vanderbilt University School of Medicine, 2215B Garland Ave, Room 1285A, MRB IV, Nashville, TN. E-mail dawood.darbar{at}vanderbilt.edu

Received April 23, 2007; accepted February 5, 2008.

Background— Genetic studies have identified ion channel gene variants in families segregating atrial fibrillation (AF), the most common arrhythmia in clinical practice. Here, we tested the hypothesis that vulnerability to AF is associated with variation in SCN5A, the gene encoding the cardiac sodium channel.

Methods and Results— We resequenced the entire SCN5A coding region in 375 subjects with either lone AF (n=118) or AF associated with heart disease (n=257). Controls (n=360) from the same population were then genotyped for the presence of mutations or rare variants identified in the AF cases. In 10 probands (2.7%), 8 novel variants not found in the control population (0%; P=0.001) were identified. All variants affect highly conserved residues in the SCN5A protein. In 6 families with >1 affected member, the novel variant cosegregated with AF. We also identified 11 rare missense variants in 12 probands (3.2%) that have previously been associated with inherited arrhythmia syndromes (eg, congenital long-QT syndrome and Brugada syndrome).

Conclusions— Mutations or rare variants in SCN5A may predispose patients with or without underlying heart disease to AF. The findings of the present study expand the clinical spectrum of disorders of the cardiac sodium channel to include AF and represent important progress toward molecular phenotyping and directed rather than empirical therapy for this common arrhythmia.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1909. [Full Text]